DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Sacral Nerve Stimulation Market 2017-2021" report to their offering.
The global sacral nerve stimulation market to grow at a CAGR of 4.66% during the period 2017-2021.
Global Sacral Nerve Stimulation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the sales, volume, and value of SNS devices.
According to the report, one of the major drivers for this market is increasing R&D efforts by companies in SNS market. Medtronic has a monopoly in the SNS market, with both implantable and external SNS devices in its portfolio. There are other companies focusing on this market by investing in R&D to launch new devices.
The latest trend gaining momentum in the market is O-arm guided navigation in patients with partial sacral agenesis. SNS lead implantation is a direct procedure for patients with intact spinal vertebrae. Anorectal malformations are usually associated with congenital sacral deformity. In case of sacral anomalies, the anatomical and radiological reference points used in placing the electrode may be difficult to identify or even absent.
Further, the report states that one of the major factors hindering the growth of this market is unfavorable reimbursement scenario for SNS procedures. In the recent years, medical facilities across different geographical regions have been using SNS devices in the management of gastrointestinal and urological disorders like fecal and urinary incontinence.
- Increasing geriatric population with sacral nerve issues
- Increasing R&D efforts by companies in SNS market
- Untapped emerging countries for SNS adoption
- Side-effects concerned with use of SNS devices
- Magnetic sphincter augmentation posing a threat to SNS in treating severe fecal incontinence
- Unfavorable reimbursement scenario for SNS procedures
- O-arm guided navigation in patients with Partial sacral agenesis
- Bioabsorbable antibacterial technology to minimize the postsurgical infections
- Increasing potential use of SNS devices in emerging indications
Other prominent vendors
- Axonics Modulation Technologies
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Research Methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by end-user
Part 08: Geographical segmentation
Part 09: Market drivers
Part 10: Impact of drivers
Part 11: Market challenges
Part 12: Impact of drivers and challenges
Part 13: Market trends
Part 14: Vendor landscape
For more information about this report visit http://www.researchandmarkets.com/research/tmxlck/global_sacral